<SEC-DOCUMENT>0001193125-23-177492.txt : 20230628
<SEC-HEADER>0001193125-23-177492.hdr.sgml : 20230628
<ACCEPTANCE-DATETIME>20230628160600
ACCESSION NUMBER:		0001193125-23-177492
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230627
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230628
DATE AS OF CHANGE:		20230628

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeuroPace Inc
		CENTRAL INDEX KEY:			0001528287
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				223550230
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40337
		FILM NUMBER:		231052132

	BUSINESS ADDRESS:	
		STREET 1:		455 N. BERNARDO AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		6502372700

	MAIL ADDRESS:	
		STREET 1:		455 N. BERNARDO AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d506395d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:npce="http://neuropace.com/20230627" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-06-27_to_2023-06-27">NeuroPace Inc</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-06-27_to_2023-06-27">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-06-27_to_2023-06-27">0001528287</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="npce-20230627.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-06-27_to_2023-06-27"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001528287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-27</xbrli:startDate> <xbrli:endDate>2023-06-27</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-06-27_to_2023-06-27">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-06-27_to_2023-06-27" format="ixt:datemonthdayyearen">June 27, 2023</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">NEUROPACE, INC.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-06-27_to_2023-06-27" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-06-27_to_2023-06-27">001-40337</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-06-27_to_2023-06-27">22-3550230</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-06-27_to_2023-06-27">455 N. Bernardo Avenue</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-06-27_to_2023-06-27">Mountain View</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-06-27_to_2023-06-27">CA</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-06-27_to_2023-06-27">94043</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-06-27_to_2023-06-27">(650)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-06-27_to_2023-06-27">237-2700</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration:underline">see</span> General Instructions A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-06-27_to_2023-06-27" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-06-27_to_2023-06-27" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-06-27_to_2023-06-27" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-06-27_to_2023-06-27" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-06-27_to_2023-06-27">Common Stock, $0.001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-06-27_to_2023-06-27">NPCE</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-06-27_to_2023-06-27" format="ixt-sec:exchnameen">Nasdaq Global Market</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-06-27_to_2023-06-27" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2023-06-27_to_2023-06-27" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Resignation of Chief Executive Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace&#8217;s board of directors (the &#8220;Board&#8221;), in each case effective as of July&#160;10, 2023 (the &#8220;Separation Date&#8221;). Mr.&#160;Favet will participate in NeuroPace&#8217;s Officer Severance Benefit Plan which provides severance and change in control benefits under certain circumstances following termination of employment with NeuroPace. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Mr.&#160;Favet&#8217;s resignation, NeuroPace and Mr.&#160;Favet entered into a consulting agreement (the &#8220;Consulting Agreement&#8221;), effective as of the Separation Date. Pursuant to the Consulting Agreement, Mr.&#160;Favet will serve as an advisor and provide consulting services to NeuroPace for a period of 12 months from the Separation Date, to assist with a smooth transition of his duties. During this advisory period, Mr.&#160;Favet will be paid a consulting fee equal to $600 per hour and will receive a cash payment in an amount equivalent to the amount Mr.&#160;Favet would have received as an employee of NeuroPace under NeuroPace&#8217;s bonus plan for 2023, <span style="white-space:nowrap">pro-rated</span> and to be paid consistent with NeuroPace&#8217;s bonus payout timeline. In addition, his outstanding equity awards will not continue to vest after August&#160;1, 2023, but will remain outstanding exercisable in accordance with the terms and conditions of the applicable award agreements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Consulting Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the complete text of the Consulting Agreement, which is filed as exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Chief Executive Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date. Mr.&#160;Becker was appointed as a Class&#160;I director, with his term in office expiring upon NeuroPace&#8217;s 2025 Annual Meeting of Stockholders. Mr.&#160;Becker is not currently expected to serve on any committees of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Becker, age 55, most recently served as President at Viking North Ventures, a firm providing advisory services to medical technology and healthcare companies and investors, from October 2022 to July 2023, in which role he was responsible for providing advisory, leadership and strategy development services. From April 2019 to October 2022, Mr.&#160;Becker served as President of the Cardiac Rhythm Management and Neuromodulation product category of Integer Holdings Corporation, a global medical device company, in which role he was responsible for overseeing commercial and operational strategy and execution. Prior to joining Integer, Mr.&#160;Becker served as Chief Executive Officer of Xchange Labs, LLC, a healthcare technology SaaS company that develops connectivity products and services focused on providing caregivers access to patient management data and integration with health plan medication management services, from May 2017 to August 2018, in which role he was responsible for commercial and operational execution. From 2004 to 2016, Mr.&#160;Becker served in various leadership roles at St. Jude Medical, a global medical device manufacturer acquired by Abbott Laboratories in 2017, including President, Americas Division, from 2013 to 2016, and President, United States Division, from 2011 to 2013. Mr.&#160;Becker earned a B.A. in Business Administration from Augustana College and an M.B.A from the University of Minnesota. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of an offer letter (the &#8220;Offer Letter&#8221;), dated June&#160;27, 2023, between Mr.&#160;Becker and NeuroPace, Mr.&#160;Becker&#8217;s base salary will be $520,000 per year and his annual target bonus will be 75% of his base salary. Bonus amounts will be determined based upon achievement of goals agreed upon with the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NeuroPace has agreed to grant Mr.&#160;Becker an option to purchase 380,424 shares of NeuroPace&#8217;s common stock, with an exercise price equal to the fair market value on the date of the grant (the &#8220;Option Award&#8221;). 25% of the shares subject to the Option Award will vest on the first anniversary of the effective date of Mr.&#160;Becker&#8217;s appointment as Chief Executive Officer, and the remaining 75% of the shares subject to the Option Award will vest in equal monthly installments over the following 36 months, subject to Mr.&#160;Becker&#8217;s continuous service with NeuroPace through each such vesting date. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Offer Letter, Mr.&#160;Becker is eligible to participate in the employee benefit plans generally available to NeuroPace&#8217;s employees and is subject to customary confidentiality covenants and is also eligible for severance benefits under NeuroPace&#8217;s Officer Severance Benefit Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NeuroPace has also entered into its standard form of indemnification agreement with Mr.&#160;Becker. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Offer Letter does not purport to be complete and is subject to, and qualified in its entirety by, the complete text of the Offer Letter, which is filed as exhibit 10.2 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;9.01 Financial Statements and Exhibits. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d506395dex101.htm">Consulting Agreement dated June&#160;28, 2023, by and between NeuroPace and Michael Favet </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d506395dex102.htm">Offer Letter dated June&#160;27, 2023, by and between the NeuroPace and Joel Becker </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">NeuroPace, Inc.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Dated: June&#160;28, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Irina Ridley</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Irina Ridley</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Legal Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d506395dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NEUROPACE, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONSULTING AGREEMENT </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective<B>
</B>July&nbsp;10, 2023 (the &#147;Effective Date&#148;), this Consulting Agreement (<B><I>&#147;Agreement&#148;</I></B>) is by and between NeuroPace, Inc., a corporation having a place of business at 455 N. Bernardo Ave, Mountain View, California
94043 (<B><I>&#147;NeuroPace&#148;</I></B> or <B><I>&#147;Company&#148;</I></B>) and Michael Favet (<B><I>&#147;Consultant&#148;</I></B>), at [***] (collectively, <B><I>&#147;the Parties&#148;)</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS,</B> Consultant previously served as the President and Chief Executive Officer of the Company, and as a member of the Board of Directors of the
Company (the <B><I>&#147;Board&#148;</I></B>) and possesses valuable experience regarding the Company&#146;s business and operations; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS,</B> the
Board and Consultant have mutually agreed that Consultant shall cease to be the Company&#146;s President and Chief Executive Officer, and as a member of the Board, effective as of July&nbsp;10, 2023; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS,</B> the Company desires to retain the consulting and advisory services of Consultant for a transition period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE,</B> in consideration of the foregoing and the mutual covenants and undertakings set out below, the Parties herby agree as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Consulting Relationship.</U> </B>From time to time, NeuroPace anticipates engaging Consultant to render
such consulting and advisory services (<B><I>&#147;Services&#148;</I></B>) as requested by the Company, it being understood that the nature of the consulting services shall consist of providing advice and consultation in connection with the
management of the business and such other matters as reasonably requested by the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Compensation</U>.</B> As consideration for the Services to be provided by Consultant throughout the
Consulting Relationship, NeuroPace will pay Consultant for the Services at the rate of $600 per hour in quarter hour increments. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">NeuroPace will pay Consultant 30 days (<B>net 30)</B> following receipt of Consultant&#146;s invoice for the work done during the prior month.
Consultant will maintain accurate records to support the invoices, which will be available for review if requested by NeuroPace. Consultant travel time will not be compensable as hours worked unless Consultant is providing the Services during the
travel time. NeuroPace will reimburse Consultant for expenses in connection with performing the Services as set forth in the Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As
additional consideration for the provision of Services under this Agreement, and subject to Consultant&#146;s continued Service under this Agreement through the bonus payment date, Company will pay Consultant a cash payment in an amount equivalent
to the amount Consultant would have received as an employee of the Company under the Company&#146;s bonus plan for 2023, <FONT STYLE="white-space:nowrap">pro-rated</FONT> and to be paid consistent with the Company&#146;s bonus payout timeline. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 of 6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Parties agree that all unvested equity awards previously granted to Consultant while an
employee of the Company will be cancelled and not be eligible to vest effective August&nbsp;1, 2023, notwithstanding Consultant&#146;s continuous service. The post-termination exercise period for all previously vested outstanding stock options
granted to Consultant during the term of his employment shall be tolled during the Consulting Period, as defined below. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Term and Termination</U>. </B>This Agreement shall have a term extending through July 09, 2024
(<B><I>&#147;Consulting Period&#148;)</I></B> unless mutually extended or terminated in writing by the Parties. In the event of termination, NeuroPace will pay Consultant for Services performed prior to the effective date of termination. Consultant
will provide NeuroPace with all work product completed prior to the effective date of termination. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Relationship Details</U>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(a)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Independent Contractor</U>. Consultant&#146;s relationship with NeuroPace will be that of an
independent contractor. Consultant will not be eligible for any employee benefits from NeuroPace, nor will NeuroPace make deductions from payments made to Consultant for taxes, all of which will be Consultant&#146;s responsibility. Consultant agrees
to indemnify and hold NeuroPace harmless from any liability for, or assessment of, any such taxes imposed on NeuroPace by relevant taxing authorities. Consultant will have no authority to enter into contracts that bind NeuroPace or create
obligations on the part of NeuroPace. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(b)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Best Efforts</U>. Consultant agrees that the work performed hereunder will represent
Consultant&#146;s best efforts to provide the Services in a manner satisfactory to NeuroPace. Consultant agrees that the Services provided will be with highest professional standards and quality. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(c)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U></U><U></U></B><U>Work for Hire<B></B></U><B></B>. It is the intention of the Parties that all right,
title and ownership in any reports, advice, opinions, guidance, surveys, marketing, promotional, and collateral materials prepared by Consultant in connection with the Services (the &#147;Deliverables&#148;) shall vest in NeuroPace. The parties
expressly acknowledge that the Deliverables shall be considered &#147;work(s) made for hire&#148; within the meaning of the copyright laws of the United States, and that NeuroPace is entitled to all rights in the Deliverables, including, but not
limited to, the modification and use of the Deliverables as determined in its sole and absolute discretion. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Use of NeuroPace&#146;s Name</U>.</B> In connection with this Agreement, Consultant agrees not to use
NeuroPace&#146;s name in any form of publicity, or to release to the public any information relating to the Services to be performed hereunder, or to otherwise disclose or advertise that the Consultant has entered into this Agreement, except with
specific prior approval in writing by NeuroPace or for purposes of compliance with governmental requirements (e.g., tax reporting requirements). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 of 6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Confidential Information.</U> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(d)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Definition</U>. &#147;Confidential Information&#148; may be oral or contained in various media or
other tangible things, including but not limited to all trade secrets, processes, proprietary data, pricing, technology and product information, business and corporate data, marketing strategies, drafts, copy, sales forecasts, outlooks, strategies,
financial information, projections, proprietary records of research data and observations, records and results of preclinical and clinical trials, regulatory filings or draft regulatory filings, computer programs, manuals, plans, drawings, designs,
specifications, supply and customer lists, internal financial data, and other documents and records, materials, systems, objects, prototypes, samples and other items whether or not labeled or identified as &#147;Confidential&#148; or prepared in
full or in part by Consultant. Confidential Information may relate to any aspect of NeuroPace&#146;s business that is either information not known by actual or potential competitors of NeuroPace or is the proprietary information of NeuroPace or a
third party (including customers, suppliers, patients, and other parties with which NeuroPace contracts or has contracts). Confidential Information includes NeuroPace trade secrets, which include certain of the data in the NeuroPace medical devices
(e.g., the RNS<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> System). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(e)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Obligations</U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(i)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Consultant&#146;s Obligations</U>. Consultant agrees not to use any Confidential Information for
Consultant&#146;s own use or for any purpose other than to carry out the Services described herein. Consultant will maintain all Confidential Information in confidence, and will not disclose it to any third party without the advance and express
written consent of NeuroPace. Consultant will protect all Confidential Information with the same degree of care Consultant normally uses in protecting Consultant&#146;s own confidential and proprietary information, but in no case with any less than
reasonable care. Consultant agrees to notify NeuroPace in writing of any actual or suspected misuse, misappropriation or unauthorized disclosure of Confidential Information which may come to Consultant&#146;s attention. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(ii)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Obligations of Consultant&#146;s Employees and Agents</U>. Consultant will make its officers,
directors, employees, agents, and contractors and subcontractors, if any, aware of Consultant&#146;s obligations under this paragraph 6, and will require such officers, directors, employees, agents, and contractors and subcontractors to execute the
appropriate contracts to ensure that the obligations under this paragraph 6 are met. Consultant will be responsible for breaches of the obligations set forth in this paragraph 6 by its officers, directors, employees, agents, and contractors and
subcontractors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(f)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Limitation on Restrictions</U>.<B> </B>Confidential Information shall not include information that:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(i)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>is or becomes a part of the public domain without breach of this Agreement by Consultant;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(ii)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>is legitimately known by Consultant, without restriction, at the time of disclosure, as demonstrated by
files in existence at the time of disclosure; <B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(iii)</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is disclosed with the prior written approval of NeuroPace; <B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(iv)</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is independently developed by Consultant without any use of the Confidential Information of NeuroPace as
demonstrated by files created at the time of such independent development; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 of 6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(v)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>is disclosed pursuant to the order or requirement of a court, administrative agency, or other
governmental body; provided, however, that Consultant notifies NeuroPace prior to such disclosure and cooperates with NeuroPace in the event NeuroPace elects to legally contest and avoid or restrict such disclosure, such as by a protective order.<B>
</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(g)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U></U></B><U>Survival</U><B></B>. Consultant&#146;s obligations under this paragraph 6 will survive any
termination of this Agreement and will continue for a period terminating on the later to occur of the date (a)&nbsp;three years following the date of this Agreement or (b)&nbsp;three years from the date on which any Confidential Information is last
disclosed by NeuroPace to Consultant under this Agreement, unless the Confidential Information constitutes a trade secret, in which case the <FONT STYLE="white-space:nowrap">non-use</FONT> and <FONT STYLE="white-space:nowrap">non-disclosure</FONT>
obligations will apply to the trade secret for so long as NeuroPace maintains the trade secret as a trade secret. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(h)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Remedy for Breach of Confidentiality Obligations</U>. In the event of a breach or a threatened breach
of the provisions of this paragraph 6, damages to be suffered by NeuroPace will not be fully compensable in money damages alone, and accordingly, NeuroPace or any third party owner of Confidential Information, in addition to other available legal or
equitable remedies, will be entitled to an injunction against such breach or threatened breach without a requirement to post a bond. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Return of Confidential Information and Deliverables</U>.</B> At NeuroPace&#146;s request, Consultant
agrees to destroy or deliver to NeuroPace and not to keep in Consultant&#146;s possession, recreate, or deliver to anyone else, any and all electronic or hard copy records of Confidential Information and documents developed by Consultant in
connection with the Deliverables or otherwise belonging to NeuroPace. NeuroPace may ask for, and if so, Consultant will provide, written confirmation that all such Confidential Information and documents relating to or embodying the Deliverables have
been destroyed or delivered to NeuroPace. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Indemnification</U>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(i)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Consultant&#146;s Indemnification of NeuroPace</U>. Consultant will indemnify, defend, and hold
harmless NeuroPace and its officers, directors, employees, agents, subsidiaries and other affiliates from and against any and all claims, damages, costs, liabilities, and expenses (including attorneys&#146; fees and related disbursements or court
costs) (collectively &#147;Claims&#148; regarding (a)&nbsp;any failure by Consultant to perform any covenant or agreement of Consultant set forth herein; or (b)&nbsp;personal injury, death, or property damage to Consultant or its agents during the
performance of the Services due to the negligence and/or willful acts of Consultant or its agents. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(j)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U></U><U></U></B><U>Intellectual Property Indemnity<B></B></U><B></B>. Consultant will indemnify, hold
harmless, and defend NeuroPace from and against any and all claims or actions brought against NeuroPace to the extent based on an assertion that any of the Services infringe or infringed a patent, copyright, or trademark or otherwise violated a
trade secret or other legally protected proprietary right. Consultant will pay all costs, fees (including attorneys&#146; fees) and damages incurred by NeuroPace in connection with any such claim or action. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 of 6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(k)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Notice of Claims</U>. An indemnified party will give the indemnifying party prompt notice of any
claim or action that could give rise to a claim for indemnity under this Agreement and the indemnified party will cooperate with the indemnifying party in the defense of the claim for which indemnity is provided. The indemnifying party shall be
permitted to defend the claim and make all decisions thereto, including but not limited to hiring counsel of its choosing. The indemnifying party shall also have the sole right to settle any indemnified legal claim provided that it obtains a
complete release for the indemnified party. This Section will survive the termination or expiration of this Agreement for any reason. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(l)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Consequential Damages</U>. EXCEPT AS OTHERWISE PROVIDED IN SECTIONS 6 (LIABILITY FOR BREACH OF
CONFIDENTIALITY) AND SECTION 9 (LIABILITY FOR INDEMNIFICATION), IN NO EVENT SHALL EITHER PARTY BE LIABLE UNDER THIS AGREEMENT TO THE OTHER PARTY OR ANY THIRD PARTY FOR CONSEQUENTIAL, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, PUNITIVE, OR ENHANCED
DAMAGES, LOSS PROFITS OR REVENUES ARISING OUT OF, RELATING TO, OR IN CONNECTION WITH ANY BREACH OF THIS AGREEMENT, REGARDLESS OF (I)&nbsp;WHETHER SUCH DAMAGES WERE FORESEEABLE, (II)&nbsp;WHETHER OR NOT A PARTY WAS ADVISED FOR THE POSSIBILITY OF SUCH
DAMAGES AND (III)&nbsp;THE LEGAL OR EQUITABLE THEORY (CONTRACT, TORT, OR OTHERWISE) UPON WHICH THE CLAIM IS BASED. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>General Provisions</U>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(m)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Notices</U>. Any notices or communications required or permitted to be given by this Agreement must
be (i)&nbsp;given in writing and (ii)&nbsp;personally delivered or mailed, by prepaid, certified mail or overnight courier, or transmitted by email transmission (including PDF) to the party to whom such notice or communication is directed, to the
mailing address or regularly-monitored email address of such party as follows: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>If to NeuroPace:</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>If to Consultant:</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">NeuroPace, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Michael Favet</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">455&nbsp;N.&nbsp;Bernardo&nbsp;Ave</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Address: [***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Mountain View, CA 94043</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Address [***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attention: </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Legal Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Email&nbsp;Address: [***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email Address: </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">iridley@neuropace.com</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(n)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Choice of Law</U>. The laws of the State of California will govern the validity, interpretation,
construction and performance of this Agreement, without giving effect to the principles of conflict of laws. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(o)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Severability</U>. If one or more provisions of this Agreement are held to be unenforceable under
applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i)&nbsp;such provision will be excluded from this
Agreement, (ii)&nbsp;the balance of the Agreement will be interpreted as if such provision were so excluded and (iii)&nbsp;the balance of the Agreement will be enforceable in accordance with its terms. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 of 6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(p)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U></U></B><U>Survival</U><B></B>. Any provision of this Agreement that is intended to be observed and
performed by the parties after termination, including as applicable the representations and warranties hereof and the provisions of paragraphs 5, 6, 7, 8 and 9, will survive the termination of this Agreement for any reason. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(q)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U></U></B><U>Counterparts</U><B></B>. This Agreement may be executed in counterparts, each of which will be
deemed an original, but all of which together will constitute one and the same instrument. Execution of this Agreement may be confirmed by the exchange of facsimiles or portable document format (&#147;pdf&#148;) files evidencing the signatures of
the parties. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(r)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U></U></B><U>Arbitration</U><B></B>. Any dispute or claim arising out of or in connection with any
provision of this Agreement, excluding paragraph 6 hereof, will be finally settled by binding arbitration in Palo Alto, California in accordance with the rules of the American Arbitration Association by one arbitrator appointed in accordance with
said rules. The arbitrator will apply California law, without reference to rules of conflicts of law or rules of statutory arbitration, to the resolution of any dispute. Judgment on the award rendered by the arbitrator may be entered in any court
having jurisdiction thereof. Notwithstanding the foregoing, the parties may apply to any court of competent jurisdiction for preliminary or interim equitable relief, or to compel arbitration in accordance with this paragraph, without breach of this
arbitration provision. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(s)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Entire Agreement</U><B></B>. This Agreement sets forth all of the covenants, promises, agreements,
warranties, representations, conditions and understandings of the parties and supersedes and terminates all prior agreements between the parties with respect to the subject matter of this Agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By signing this Agreement, the Parties agree to the Effective Date and terms, as set forth above. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>NEUROPACE, INC.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>CONSULTANT&#146;S LEGAL NAME</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Frank Fischer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Favet</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(signature)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(signature)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Frank Fischer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date Signed: June&nbsp;28, 2023</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chairman of the Board</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date Signed: June&nbsp;28, 2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 of 6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d506395dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g506395dsp1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">June&nbsp;27, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joel D. Becker </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>via email </I></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Offer Letter and Employment Agreement </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Joel: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NeuroPace, Inc. (&#147;<B>NeuroPace</B>&#148; or the
&#147;<B>Company</B>&#148;) is pleased to offer you the position of President and Chief Executive Officer (&#147;<B>CEO&#148;)</B> pursuant to the terms set forth in this offer letter agreement (the &#147;<B>Agreement</B>&#148;). Capitalized terms
will have the definitions and meanings set forth herein. The terms of your new position with the Company are as set forth below: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1.
E<SMALL>MPLOYMENT</SMALL> B<SMALL>Y</SMALL> T<SMALL>HE</SMALL> C<SMALL>OMPANY</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) Position.</B> You will serve as the
Company&#146;s President and Chief Executive Officer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) Duties.</B> You will perform those duties and responsibilities as are
customary for the position of President and Chief Executive Officer and as may be directed by the Board of Directors, to whom you will report. You will also be appointed to the Board of Directors. <B></B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c) Location. </B>You will work a minimum of three (3)&nbsp;days per week out of the Company&#146;s offices in Mountain View, California (or
traveling on Company business) and the other days remotely from your home, both locations of which will be considered your primary places of employment. Notwithstanding the foregoing, the Company reserves the right to reasonably require you to
perform your duties at places other than your primary places of employment from time to time, and to require reasonable business travel.<B> </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d) Start Date. </B>If you find the terms of this letter agreeable, you will commence this new position with the Company on a mutually
agreed upon date no later than July&nbsp;10, 2023.<B> </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e) Proof of Right to Work. </B>For purposes of federal immigration law, you
will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided within three (3)&nbsp;business days of your date of hire. <B></B> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f) Outside Activities.</B> Throughout your employment with the Company, you may engage
in civic and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> activities so long as such activities do not interfere with the performance of your duties hereunder or present a conflict of interest with
the Company. During your employment by the Company, except on behalf of the Company, you will not directly or indirectly serve as an officer, director, stockholder, employee, partner, proprietor, investor, joint venturer, associate, representative
or consultant of any other person, corporation, firm, partnership or other entity whatsoever known by you to compete with the Company (or is planning or preparing to compete with the Company), anywhere in the world, in any line of business engaged
in (or planned to be engaged in) by the Company; provided, however, that you may purchase or otherwise acquire up to (but not more than) one percent (1%) of any class of securities of any enterprise (but without participating in the activities of
such enterprise) if such securities are listed on any national or regional securities exchange.<B> </B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. C<SMALL>OMPENSATION</SMALL>
A<SMALL>ND</SMALL> B<SMALL>ENEFITS</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) Base Salary.</B> You will be paid a base salary at the rate of $ 520,000.00 per
year. Your base salary will be paid on the Company&#146;s ordinary payroll cycle, less applicable payroll deductions and withholdings. As an exempt salaried employee, you will be required to work the Company&#146;s normal business hours, and such
additional time as appropriate for your work assignments and position, and you will not be entitled to overtime compensation.<B> </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) Employee Benefits.</B> As a regular full-time employee, you will be eligible to participate in the Company&#146;s standard employee
benefits offered to executive level employees, as in effect from time to time and subject to the terms and conditions of the benefit plans and applicable Company policies. A full description of these benefits is available upon request. Subject to
the terms of this Agreement, the Company may change your compensation and benefits from time to time in its discretion.<B> </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)
Annual Discretionary Bonus.</B> You will also be eligible to earn an annual discretionary bonus with a target amount equal to 75% of your annual base salary. The amount of this bonus to be paid out will be determined in the sole discretion of the
Company and its Board of Directors and is based, in part, on your performance and the performance of the Company during the calendar year, as well as any other criteria the Company or the Board of Directors deem relevant, as set forth in the
Company&#146;s Employee Cash Incentive Plan or any successor cash incentive program sponsored by the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c) Equity Compensation.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i) Option Grant: </B>In connection with the commencement of your employment, and to induce you to accept this employment offer,
the Company will recommend that the Board of Directors grant you an option to purchase 380,424 shares of the Company&#146;s Common Stock (&#147;Shares&#148;) with an exercise price equal to the fair market value on the date of the grant. This is
equivalent to 1.5% of fully diluted shares. 25% of these option shares will vest one year after your employment start, with the balance of the shares vesting at the rate of 1/36th per month over the next thirty six months. Vesting will, of course,
depend on your continued employment with the Company. The option will be subject to the terms of the Company&#146;s inducement plan and the Stock Option Agreement between you and the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g506395dsp1b.jpg" ALT="LOGO">
 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d) Officer Severance Benefit Plan.</B> You will be eligible to participate in the
Company&#146;s Officer Severance Benefit Plan (the &#147;<B><I>Severance Plan&#148;)</I></B> subject to the terms and conditions of the Severance Plan, including but not limited to the &#147;parachute payment best
<FONT STYLE="white-space:nowrap">after-tax&#148;</FONT> treatment set forth in the Severance Plan, which shall be applicable with respect to any payments or benefits you may receive from the Company or otherwise in connection with any change in
control of the Company, whether pursuant to the Severance Plan or otherwise. A copy of the Severance Plan has been provided to you concurrently with this Agreement. The foregoing to the contrary notwithstanding, your participation agreement under
the Severance Plan shall be in the form attached hereto as Exhibit A. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e) Expenses.</B> The Company will reimburse you for reasonable
travel, entertainment or other expenses incurred by you in furtherance of or in connection with the performance of your duties hereunder, in accordance with the Company&#146;s expense reimbursement policies and practices as in effect from time to
time. The Company will pay your reasonable professional fees incurred to negotiate and prepare this Agreement and the agreements referenced herein.<B> </B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. C<SMALL>ONFIDENTIAL</SMALL> I<SMALL>NFORMATION</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) Confidentiality Information and Invention Assignment Agreement.</B> Your acceptance of this offer and commencement of employment with
the Company is contingent upon the execution, and delivery to an officer of the Company, of the Company&#146;s Confidential Information and Invention Assignment Agreement, a copy of which is included for your review and execution as Attachment A
(the &#147;<B>Confidentiality Agreement&#148;),</B> prior to or on your Start Date.<B> </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) Conflicting Obligations.</B> You agree
not to bring to the Company or use in the performance of your responsibilities at the Company any information, materials or documents of a former employer that are not generally available to the public, unless you have obtained express written
authorization from the former employer for their possession and use. You also agree to honor all obligations to former employers during your employment with the Company.<B> </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. A<SMALL>T</SMALL><FONT STYLE="white-space:nowrap">-W</FONT><SMALL>ILL</SMALL> E<SMALL>MPLOYMENT</SMALL> R<SMALL>ELATIONSHIP</SMALL>. </B>Your employment
relationship with the Company is at will. Accordingly, you may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying the Company; and the Company may terminate your employment at any time, with or
without Cause or advance notice, subject to your participation agreement under the Severance Plan. If your employment is terminated by you or the Company for any reason, you agree to resign from any position you hold on the Company&#146;s Board of
Directors (&#147;<B><I>Board&#148;),</I></B> to be effective no later than the date of your termination (or such other date as requested by the Board). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. C<SMALL>OMPLIANCE</SMALL> W<SMALL>ITH</SMALL> O<SMALL>R</SMALL> E<SMALL>XEMPTION</SMALL> F<SMALL>ROM</SMALL> S<SMALL>ECTION</SMALL> 409A. </B>It is
intended that the benefits set forth in this Agreement satisfy, to the greatest extent possible, the exemptions from the application of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, (the &#147;<B><I>Code&#148;)</I></B> (Section
409A, together with any state law of similar effect, &#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A&#148;)</I></B> provided under Treasury Regulations <FONT STYLE="white-space:nowrap">1.409A-1(b)(4),</FONT> 1.409A- 1(b)(5) and <FONT
STYLE="white-space:nowrap">1.409A-1(b)(9).</FONT> With respect to reimbursements or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided to you hereunder (or otherwise) that are not exempt from Section&nbsp;409A, the following rules
shall apply: (i)&nbsp;the amount of expenses eligible for reimbursement, or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided, during any one of your taxable years shall not affect the expenses eligible for reimbursement, or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefit to be provided in any other taxable year, (ii)&nbsp;in the case of any reimbursements of eligible expenses, reimbursement shall be made on or before the last day of your taxable year following the
taxable year in which the expense was incurred, (iii)&nbsp;the right to reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits shall not be subject to liquidation or exchange for another benefit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g506395dsp1b.jpg" ALT="LOGO">
 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. I<SMALL>NDEMNIFICATION</SMALL> A<SMALL>GREEMENT</SMALL>. </B>You and the Company will enter into an
indemnification agreement, which may be amended from time to time, and will be subject to the terms as then currently in effect. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7.
D<SMALL>ISPUTE</SMALL> R<SMALL>ESOLUTION</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) Arbitration Agreement</B>. To ensure the rapid and economical resolution of
disputes that may arise in connection with your employment with the Company, you and the Company agree that any and all disputes, claims, or causes of action, in law or equity, including but not limited to statutory claims, arising from or relating
to the enforcement, breach, performance, or interpretation of this Agreement, your employment with the Company, or the termination of your employment, shall be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. &#167; <FONT
STYLE="white-space:nowrap">1-16,</FONT> to the fullest extent permitted by law, by final, binding and confidential arbitration conducted by JAMS, Inc. or its successor (&#147; <B><I>JAMS&#148;),</I></B> under JAMS&#146; then applicable rules and
procedures for employment disputes before a single arbitrator (available upon request and also currently available at <U>http://www.jamsadr.com/rules-employment-arbitration/</U>). <B>You acknowledge that by agreeing to this arbitration procedure,
both you and the Company waive the right to resolve any such dispute through a trial by jury or judge or administrative proceeding</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) Individual Claims.</B> All claims, disputes, or causes of action under this section, whether by you or the Company, must be brought in
an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated with the claims of any other person or entity. The arbitrator may not
consolidate the claims of more than one person or entity, and may not preside over any form of representative or class proceeding. To the extent that the preceding sentences regarding class claims or proceedings are found to violate applicable law
or are otherwise found unenforceable, any claim(s) alleged or brought on behalf of a class shall proceed in a court of law rather than by arbitration. This paragraph shall not apply to any action or claim that cannot be subject to mandatory
arbitration as a matter of law, including, without limitation, claims brought pursuant to the California Private Attorneys General Act of 2004, as amended, the California Fair Employment and Housing Act, as amended, and the California Labor Code, as
amended, to the extent such claims are not permitted by applicable law to be submitted to mandatory arbitration and such applicable law(s) are not preempted by the Federal Arbitration Act or otherwise invalid (collectively, the &#147;<B><I>Excluded
Claims&#148;)</I></B>. In the event you intend to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be publicly filed with a court, while any other claims will remain subject to mandatory
arbitration.<B> </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c) Process. </B>You will have the right to be represented by legal counsel at any arbitration proceeding.
Questions of whether a claim is subject to arbitration under this agreement shall be decided by the arbitrator. Likewise, procedural questions which grow out of the dispute and bear on the final disposition are also matters for the arbitrator. The
arbitrator shall: (a)&nbsp;have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b)&nbsp;issue a written statement signed by the arbitrator regarding
the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator&#146;s essential findings and conclusions on which the award is based. The arbitrator shall be authorized to award all
relief that you or the Company would be entitled to seek in a court of law. The Company shall pay all JAMS arbitration fees in excess of the administrative fees that you would be required to pay if the dispute were decided in a court of law.<B> </B>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g506395dsp1b.jpg" ALT="LOGO">
 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8.</B><B> </B><B>Injunctive Relief</B>. Nothing in this letter agreement is intended to prevent either
you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state
courts of any competent jurisdiction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9.</B><B> </B><B>M</B><B><SMALL>ISCELLANEOUS</SMALL></B><SMALL><B></B></SMALL><B>. </B>This Agreement, together
with your Confidentiality Agreement and Indemnification Agreement, forms the complete and exclusive statement of your employment agreement with the Company. It supersedes any other agreements or promises made to you by anyone, whether oral or
written. Changes in your employment terms, other than those changes expressly reserved to the Company&#146;s or the Board&#146;s discretion in this Agreement, require a written modification approved by the Company and signed by a duly authorized
officer of the Company (other than you). This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. If
any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this Agreement and the provision in question shall be modified so as to be rendered
enforceable in a manner consistent with the intent of the parties insofar as possible under applicable law. This Agreement shall be construed and enforced in accordance with the laws of the State of California without regard to conflicts of law
principles. Any ambiguity in this Agreement shall not be construed against either party as the drafter. Any waiver of a breach of this Agreement, or rights hereunder, shall be in writing and shall not be deemed to be a waiver of any successive
breach or rights hereunder. This Agreement may be delivered and executed via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other
applicable law) or other transmission method and shall be deemed to have been duly and validly delivered and executed and be valid and effective for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please sign and date this Agreement and return a signed copy to me on or before June 26, 2023 to confirm your acceptance of this Agreement. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>N<SMALL>EUROPACE</SMALL>, I<SMALL>NC</SMALL>.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U></U><U></U>/s/ Frank M. Fischer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frank M. Fischer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chairman of the Board</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Accepted and Agreed:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U></U>/s/ Joel Becker</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>June&nbsp;28, 2023</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joel Becker</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Date</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:[***]</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g506395dsp1b.jpg" ALT="LOGO">
 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>npce-20230627.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 6/28/2023 11:47:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:npce="http://neuropace.com/20230627"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://neuropace.com/20230627"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="npce-20230627_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="npce-20230627_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>npce-20230627_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 6/28/2023 11:47:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>npce-20230627_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 6/28/2023 11:47:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="npce-20230627.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g506395dsp1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g506395dsp1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MU%'$0>YVT,T5Q"DT,B21.,JZ,""/4$5PM-.S.A.^P^D 4 % !0 4 % !0 4
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MPO\ \BEHW_7E#_Z *RK_ ,67JRZ?P(\N\%Z!J?BO3;B[?Q+?VQBE\O:KLV>
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M5J4GT_S18_X3&V_Y\KK_ +Y'^-1]4EW1K_:D/Y67=+U^'5;EH([>:(JA?+@
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MBJDG)[&IXK^'.FW>C.^BV26U_!\Z!./,]5/]/>LL/C)QG:H[HNI137NK4T_
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MI]T9GU*:X&TKL?./KUK.I64XV4;'1A\)*C/F<VS8KG.X* "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
' * "@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g506395dsp1b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g506395dsp1b.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( " "-0,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /<;J^GM[V"W6W1_/)",92.BY.1MXK6,$XMWV.:I5G"<8);[
M:^5^P]KJ9KB2&W@5VB WEY-H!/.!P<_I2Y4E=LIU).3C!;;Z_P# 9''JD<L4
M+K&P+S>0RGJC#.?Y4W3:;7E<F.(4DFEN[>A8GN!!);IMSYTGE]>GRDY_2HC&
MZ;[&LY\CBN[M^#?Z$CRQQLJO(JEN@)QFDDWL4Y16C91;5,7<UNOV=6B<)B6?
M86R >!@^M:JG[J>OW'.\1[[@K:=W;IZ"2ZJ8[BZB"0@6^-Q>;:6RH;@8]Z%2
MND^_D*6(M*4;+W>[MTOV$DU=5:W"K$@FA$H,\OEX'''0\\T*D]?)VT!XE+EM
M;57U=A]QJ?V=K93Y ,Z,X9IMJ<8Z''/WJ4:=[^7D.>(Y'%::^>G3K;S+D$AE
MA5SLY&?D;<OX'C-9M6=CHA+FC<HP:ND\EHBQY^TYP$;<8\ D[QVZ8^I HL.X
MMEJGVYHVC6)89!E29?G(QD?+C'X9XHM8+A;:I]JN"L:Q"(2-'EI<,2I(.%QC
MJ#WZ46"Y;N)7AC,@$8102[22; H'?H:0R**ZFELXKCR%C#KO8/)@*.V>/3VI
M@5FUA<VR(B"::+SMLDFT*O'< ^OIV-%A7-&)_,B1_E^8 _*V1^![TAE2VU!Y
M[JXA\I0(.&97)RW!P 0,\'KTSQZX=A"6NI"Z:)51<RQ&4;7SM''#<<'YOT-%
MK ))J36YNC-"H2VC#L4DSDG.%Y YX_4>M%@)K.Z:X+AQ"-N,".4L?QR!B@9*
MLK&[DBP-JHK#UR2W^ I 5+C4'BOFMEC!VQJ^X[CU)&. ?[M:QIIQYCFG7<:G
M(ET3Z^?9>0V_U3["T:;49]OF2 OMVJ.N/4^@]J<*7/J36Q'LFE\WKT_K8GN[
MS[-;+=*JR0#!<AN=I[CU^E1&',^7J:U*O)'G6J_0?97+7=LLY0(K\H V[Y>Q
M/O[43CRNPZ4W4CS6W*@U4O=NBJJPQR^4696.3D \@8')[]?;-38TN2F^D6]D
MB>/RXU=55V1L-D#OC'4XZ]J (Y=1F2&ZN4B0V]L6#98[F"_>(XXQS@=_:BP&
MA(7"$QA2W8,<"D,JV]U)<QS%%0A&PD@.4DX&2/IR/PI@):74]U;,YC2.0/C:
MV00,?Q#J#WQZ8HV$26-P]U;><ZJJL3L*G[R]F_'K],4MAD<=W*UV;;9&7"%F
M*,2(SQ@'COG/X=*8B!]3GB:Y+6ZO'#A=RM@-(2 %&?J,GMGOS@L%R=;JY2[2
MWGBCW21LZ%'. 1C(/'N.?TH DL+EKNS29T",2P(!R!@D?TI;#'64S7%G%,X
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M-<2;L^<X?&.GRA<?I2<KI+L5"'*Y/N[_ ()?H59M'AFDNY&;$L[*RN%^:,J
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M[LJ<KS['FBXQRV4*JX.YBY#,Q8YR!P?;IVI  M$\M4+R,RMN5V;+ XQD?@:
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MJ;BM2H5HS:2ZJZ\T6J@V"@ H * "@ H * "@ H * "@ H * "@"E>:5:WJ7
MD0AIX_+=E8@D8([?4T[V%8?/:ROY8ANGA0##+M#;A^/0^] QLUB[I'%#<-#
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MTAD*:?;I:);!/E2'R Q^\$QC&?P%.X"#3T1T>&62%UC$1*X.Y1TSD'ID_F:
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M9D8L+<7_ -L"XFV%#@\$''4>O I\\N7EZ$^Q@JGM.I';:7!:NAC)V1C"(57
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CEMT5OR_R+-0:A0 4 % !0 4 % !0 4 % !0 4 % !0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140689548997088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 27, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NeuroPace Inc<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001528287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 27,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-3550230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">455 N. Bernardo Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Mountain View<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">237-2700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NPCE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>d506395d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="npce-20230627.xsd" xlink:type="simple"/>
    <context id="duration_2023-06-27_to_2023-06-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001528287</identifier>
        </entity>
        <period>
            <startDate>2023-06-27</startDate>
            <endDate>2023-06-27</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-06-27_to_2023-06-27"
      id="Hidden_dei_EntityRegistrantName">NeuroPace Inc</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-06-27_to_2023-06-27">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-06-27_to_2023-06-27"
      id="Hidden_dei_EntityCentralIndexKey">0001528287</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-06-27_to_2023-06-27">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-06-27_to_2023-06-27">2023-06-27</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-06-27_to_2023-06-27">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-06-27_to_2023-06-27">001-40337</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-06-27_to_2023-06-27">22-3550230</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-06-27_to_2023-06-27">455 N. Bernardo Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-06-27_to_2023-06-27">Mountain View</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-06-27_to_2023-06-27">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-06-27_to_2023-06-27">94043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-06-27_to_2023-06-27">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-06-27_to_2023-06-27">237-2700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-06-27_to_2023-06-27">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-06-27_to_2023-06-27">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-06-27_to_2023-06-27">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-06-27_to_2023-06-27">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-06-27_to_2023-06-27">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-06-27_to_2023-06-27">NPCE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-06-27_to_2023-06-27">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-06-27_to_2023-06-27">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2023-06-27_to_2023-06-27">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "]@-Q6R$D;7&4$   G$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V887/B-A"&_XK&[73:F22V!022 C.$)-?T+AP-:6^FG7X0M@#-V9(KR4#^
M?5<VL6G/K/D"EO&^?K0KO9(8[I3^:C:<6[)/$VE&WL;:[-;W3;3A*3-7*N,2
M?EDIG3(+3;WV3:8YBXN@-/%I$%S[*1/2&P^+>W,]'JK<)D+RN28F3U.FW^YX
MHG8C+_3>;[R(]<:Z&_YXF+$U7W#[>S;7T/(KE5BD7!JA)-%\-?(FX>T=[;F
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M-7F& :X%2QIY<)56GMKX0]RUYYH7Z>$PP\KU&[8YL$'\O%J=J!^NUT9&ZQ6
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M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " "]@-Q6)!Z;HJT
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M2P$"% ,4    " "]@-Q6!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( +V W%9IKPA5[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M +V W%:97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ O8#<5LA)&UQE!   )Q$  !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M +V W%:?H!OPL0(  .(,   -              "  :D,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ O8#<5I>*NQS     $P(   L              ( !
MA0\  %]R96QS+RYR96QS4$L! A0#%     @ O8#<5APX9>H_ 0  / (   \
M             ( !;A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( +V
MW%8D'INBK0   /@!   :              "  =H1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( +V W%9ED'F2&0$  ,\#   3
M          "  ;\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d506395d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d506395d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d506395d8k.htm">d506395d8k.htm</File>
    <File>d506395dex101.htm</File>
    <File>d506395dex102.htm</File>
    <File>npce-20230627.xsd</File>
    <File>npce-20230627_lab.xml</File>
    <File>npce-20230627_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d506395d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d506395d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "npce-20230627_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "npce-20230627_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "npce-20230627.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "npce",
   "nsuri": "http://neuropace.com/20230627",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d506395d8k.htm",
      "contextRef": "duration_2023-06-27_to_2023-06-27",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d506395d8k.htm",
      "contextRef": "duration_2023-06-27_to_2023-06-27",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230627/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-23-177492-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-177492-xbrl.zip
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M$LC-J4-NA^-P."*7U*<FDM. :(8<"3?RC!@ [&X$^AG330-$K+Y)"Y]AD5^
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M*:97F+<A&U2C/K=V9RJ2A]FEB 9#XZVK"'X@7#K\U&[Y_,.8=! U/_^>/KS
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M2T[@<5(Q?RY9_S'ET_\'4$L#!!0    ( +V W%85K=4/H1\  .BL   1
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M# " '.^Z(\')": ):"VDN<C!H*0-AAG3+**3SLLI6%"\^6:N/!"78[!4^&U
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MQ5X[UP71G3%Q/;\^<#4DITB1QKZY8558>*K3[K[NGB^1G;\]^^65(!4=7GU
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MY?Z+0^=;\XD'"U<7(O+SO1RD<\Q1B](QF034FH2^!MP>UAM(Y8Z;U (^D9S
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MH*!ZLK1I15?F;(35]U#BO=BD,+"IS-8CCV3)]5 9WM 6Q'=BX[ 71]P/!U?
MU;X8M9)<R%!'J -&)NMI5U-G#//:;05L79R:K<7% M/#1+LSC6XKF]DD6+=3
M9<'6_:"*!E1VV 13IN1,< B#A7KCDY^FHI7:M2%!6+FFHJWMRRNHW&6*$XU.
MRHW^M]B)CVK%V)/1X.RHZNY]8W?:]2MW[=Q<NVSMO?\,3R]\C"->V*'GI^[:
ME=V.1[6A#[>?#DPS6T'I/&ST2"B>L3E+%ZVU6[\KB(CIWWRR[%E[/<4X$K-Y
MX.88XH)EI28X R_B.5M.9YA-_&@+!U<,PSE3@U1:=#%"J(]8]A)4/"E1NT+.
M[3U]\IBR\3*F%?3:T3H.;<;HZ^9-W0Z^!1<PY6#1!9@Y=GYA'QIU%T 4CL5!
MUL->(QE ,]FI^6+]MVH]33I<(,F;^!JW7 F0ZY*JD<RL>TWU3A^GWMP!=+#^
M$/<.1_7FLJ#KCS:\=J5NYR-G>[K1M[.]:83WM6"&G/Z]=,+F>0_@Q\[H5*P9
M35>=2>M^<+Y1QPVF:$ZJU-*;GG'[490NT'IG)2"(;H?C8U2ZY9Y8UZ9%KZC5
MP%SXZ))('']ZR^U]D>7V+%C@AD_/B,D/A((P'YZ;F!Y7+#DHY+WT*43>*>_5
M9-KZGQ6-:14R;;\>@;#AM&6DP9,!-?A,C ^IJ\FDHMBNH=<(C%T2(Y8A%2,H
M>33A9B#<DF!@0KE<R2Y/Y)3HJ]W3B8DG/ Z*A:QB8UJ+KQ5>G[1/X>=(OQ)G
MO0@0Z5]+'1I+F+E>(>.,F>]FDC]O%K]]GO&?+/Z?(XO_J4CG<;_*QQP/3\]&
M+T9'M9R,"TE>7@Z'?@Q1'?=HHFS*=M$BL3,5DQ*(7$(5)WIB082LL@B\U\WQ
M&0,/;CN*<&=5CL\Q):)*\;H,W5WYTR^6]_JI#Z#9@L.KB]?7PW:\=75^\GIU
MRNO;-^L-LK$N3"-_[0A@7URG($! .,H4:.?8N8<9G  B[!B$B+G?/(U*@PB[
MG5#G\[*@<RO@_%&:,KNE+O!QK=Q-K3*1S<Q$:=03%5&K#;VWASVF.L[)G088
MJW%2(^"TATX8(V985-?%\IX:#J+*$F*?I9L55X.#23')AT?4F0J^BW50898E
M,#J-1B28]?R438^SV-2KJ@H'I9L=5O<SQT2!?@BUJDO"N6<2U VLJUE@>6$.
M=-3T &'S4_&Z?]4_ZB-^?OS3LX]"HYL[CQVBM1T+913Y40827)B C@Z.P-\3
M6$($/VD^&&7*;U5*4GJT85VNM&?K?AZ<7IE#N\C7(O=:=$R\*AC5X\A6O,JX
MU=YZ_(PMAU<F(R2*]'0[ *X"!1@0?F\<0G%*;W"/%*@C\+0E&XE9W71G%#A/
M/7-5C00EWW]],"N*^=[6UF*QZ+^3<2[#K!^D\1:1MEF1L>DQ:6M_Z_7!!AU5
M(=,<8-MZI,*IV3ICLY%<LA$S-QZ/W5I[W0Z=@5NU%1=2FR/ 'O B);.]4C/+
M&CQF@T<XL/,-TXY(P#N,G( S[THDBS(J>$HP)QJXI2I0"O6!C=%WZD(=@4H"
MJ,86G",R J8+%5N)C5&HC,\*H^,2/AJC<V.';+%S94:GYPXKC8EI!=5-94)G
M+ PI@81]1P:,6DI]E&H?PB@;.U# V.C)A((S(ABV_H;@7_)<Q"H>DX?F]! >
M],IP;YE6_:QQNL*32@_;E^E<!O;4\YF+-$)0;$Y7<71!/%IU"H.L,)VO,'V-
MU69!OP&KH6*QG;,QFSMM8 \;U&9DMIAIZ+@,GBNB1B*3,J.CJ(VU.:94BR0?
MR $(62^7<9EC/9R,%3Z/M1S,54TEI3S--);:S)N03R),('PE#W.CTX@R797)
M 9M(9UAP7%58YR?*Q/@7/JQHSE3H>!W/M8*9G;(HK K4SO%(0Q4KBZ&(!$_]
M4A1-HW,$$;C#HF@G*K-@.LJPGV$*YG[F![L8I-L^ J/X5N&8:8%,VF%4C/W6
MZ&!!OSWS0ZH;2SJ;R51YCKKGSH:0IS8%#<-KN_*FD_/."%]D^@99/@ [D25J
MF8N77-- KX>OV]W>?EA/4C5F>($]>-Z7,E#77J4E 0/RG/ZSSFI6SY_(,? &
M$UTX%);NWE/3-3*@9ETVC5+SGG6E,3D X*X9X?.W9MWM^8+&!*1$]CV(1.9>
MVO46E-#L_KB!589B/8"XGE/ F/UOIOB&'[@ZV.VP16VDV2 6,15.K#N:7H!"
M\8;A EE<1H6>1\J9X K&F=0,/F_?8PRW/?\#W+\Q2<[F"!-^<"4+SX/KR!HS
MLTLH4(F4WYG,CYI.B!C/I=^KX=^U*AG0@5\$28VS^NZ3'LZ?$VXT-M(@-K!Q
M>#BZ3'(5V5I)"SJP[>QV_ALQ3G5TGIV>-&8!'6+%*'\.SV56A1.'9$,54)++
M:&;E-_KB1+]7J(D]AV" V%\=$1QC3K-TX7]HP&(4/JP@,UL2(5!*=VW1A+Y'
M@F"-;5/N/A?ATW"-F2S/F1'=>P  3:;*<=E4/XNE.PX(# VQV[?@%OV4ZOGV
M';5(JT4X<G"!-1O:V!"6X%<JL),^+;'(X[;H6+40.!?( .N8M&">EXAA3966
M4^LL 3U-5O&]<GS<N."S#%.(TMHQ9PR9OAX>U"/ 0Z0K^H &':.P#_3,:*QL
M>=S&T95EK0AQ+3QY;@*'"4<4KJ,/MGO.^NAG%YES]FQ#"XY4_7.F7JT\?L,M
M*HLBO]WAR4:)CH70.'25X_<N6NZWWC%D?#6&T? WQBFU?6):A>C8;N[:%!LX
MF@8YRAPIM1/Z\ )=UZD%GC^U.ZU-I;5?F''[<R8W'_Z3W/R;)#>?]$UM3YB_
M1\F[,N$"]25M7$8=9RE^$6+J*J>MSV518Y,MO>)W+1B@*(W6M=M959NG-!'U
MO_#,[L7&8E!>#/>5-Y_.J,6/8-E,0J2"9QC<62EGPVQ,Q4C.1^D#=,EHG"CV
M2,&R9F0FFB,=WB%I*9/;XP"#;#&&YEP)LAVJ!@42@D2_@"$:D.\"/'.J'58!
MX;W.0QW8;P)]U0^X@5"?-J5\:BNZ-A6+7_\;G W/7[LSTC3"_,@?]7!W#DU.
M]KIY]-&4GKDCA/-MM_:IF?:Y>L[;FPSCT-R(%<()97RY^D B!BVI?&\[M^<I
M9OL(RPC#!XR*06#^,3JO/93#TEACMH)J=Z:>.Z9V,8#159HBS>B8/*R9,4%?
M'%&YB_2B219EX7O^)X?X0UR!><1T@47N(T>N7;YU=+MJ^+#7O).+K0:'GOL^
M405>XC3TJ@UX=/JF=3:/M=EA&RG"$K-PSM=#-+ZRF5*LUS^KM&'BXX$G%\0-
M]M-#V,&6]TRN@E+G?O8A[U6I2W/6E[HM:6O=EH-C$*032M&G?BO(W4]Q-YTA
M:/5KL1\)LTY+KBKG*Q/5:!*],Z8<,=@H$-L6Z_D**NGB 53NY.;SHS2CG43:
M\V;U(KJ7.[J#&'?JU(V!EUCT[Q6J22?PR%MJ "?!H82^X]7M>!0S\(GQ<QJ<
MW\( TM]OY Y<($$M7[0I\G2"A^-RUU-C0IIZP-W2%T<BOJO(RJ9)OJ6!'::J
MSJ@4IL'*RS?8? G#=(XVN"LU-W@.L]L00F-(G1O_$8_UE,Z.KF@D\M.-'JE3
M<'.Y]8?$C:6IQHDPH\,L/#<ECC/.27&)9%4)!.,*C$-K+?S^D0G<X[9:4",)
M#_\Z;93^ZZHCO/2E&/OR]IM:HK'?]>,N:RL8ZF2&7_ CN1,94.,1Z+G"Y$>6
M)CH0].7<]2H],0\G]C"Q-PIWG,0OV[ C6/)I1B->K,(XSSN\ KCE9:JV>_CQ
M*TIH#JOYKC.9Y-)\Q\)/T\".KJG@1G40H\!GP!W0QHG!\*>AQ]H:6RF$I:,U
M;"IA%&UY/$ZZFD$<6_,HON-Z!">F5]=^9.S.3/^7^;+L!7V:E;C.O?.<7VX9
M$_ T)9[HM]Z!^MPQJ=-H=,$O08O=Q^8CT&9_:?LUOA4G ;RC1E_EB\K-#QTW
M/X1<0_#>!Y._[)>85WS-FS^R?&!^J#ZB_/B'-?Z\L+MC/XO,2ZU(M@/K$WSN
M\Q4!]'WCBE3+DEN^!BT^C24'#>+HF\_XF6';&/#Z\AS$YCH&>E5;QI'K%6A^
M3;JQ4J<0[1'\NL]\E!A49XZW2F^1KX:CEZ\@D-UY7'^I=UV 9H&>POR[GS!F
M!05?4SRO#["::O[:RK?$"["4[\5I7[P - JF\X\EC*_(BK_MPB'<T=B_85$6
MQ21_K-7_M??@X<& O*B!$N0_P]9W]?^1PK>PA&@"Z=^AX'^$XCL)X+7_[V\\
M8>A%=OK;\^6[,X-O?_Z?>&#R;ZG9@S#$G-3>__[XXX__]\>R*%]W/W\IS?DC
M_]GM_!&H^.NNVUG=?_;,7^;/?_;,7W_/8$&9_QFG/V/]_M%?HWX/(<SY\5NX
M2/_2X/\#4$L#!!0    ( +V W%9CM6,>0 ,  $0+   1    ;G!C92TR,#(S
M,#8R-RYX<V2]5M]OVS80?B_0_^&JIPV81,M9TD:(4W1+ P1(L\)-A[T5-'5V
MB%&D1E))_-_O2$F.8L>NFPSSBVG>?7??_:1/WM]7"F[1.FGT),FS40*HA2FE
M7DR2QJ7<"2F3]Z>O7YV\25,X.[^X@A1NO*]=P=C=W5U6SJ5V1C6>++A,F(I!
MFO;ZOU]_A3];ZP5,42%W"!5W'BW\UDA5%N/1>)SGHW?9T1!FD0=[4'*/!1RQ
M\3M&B@>0Y\6O;XO#$7S^!!^C&0W7LL(AUM1+*Q<W'GX2/T-$G1FM42E<PKG4
M7 O)%7SI*?\"%UID\$$IF :8(YX.[2V666?UWI6%$S=8\=>O "AAVA6:3#;5
M) F9Z!)Q/[,J,W;!2F^97];(2"DE+;12) /H]W$;&*I$D+@5<,[=+()Z2<C/
M>.BE%KC2UMA84W.!L3XA)Z.C\=N!=HERI1SY.!39PMPR$JQ;#G+Y= 3CT>B
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M(L42?>T1EGBV_/Z'[9*;X" OC[K /.^Z.6+>S-.;NN1O4$L! A0#%     @
MO8#<5G:X?P8)%@  KGP   X              ( !     &0U,#8S.35D.&LN
M:'1M4$L! A0#%     @ O8#<5A6MU0^A'P  Z*P  !$              ( !
M-18  &0U,#8S.35D97@Q,#$N:'1M4$L! A0#%     @ O8#<5NP 4.!P'
M<'   !$              ( !!38  &0U,#8S.35D97@Q,#(N:'1M4$L! A0#
M%     @ O8#<5F.U8QY  P  1 L  !$              ( !I%(  &YP8V4M
M,C R,S V,C<N>'-D4$L! A0#%     @ O8#<5OS2!K"2!@  JD8  !4
M         ( !$U8  &YP8V4M,C R,S V,C=?;&%B+GAM;%!+ 0(4 Q0    (
M +V W%8?4S'KT@0  #<L   5              "  =A<  !N<&-E+3(P,C,P
A-C(W7W!R92YX;6Q02P4&      8 !@!_ 0  W6$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
